The report was filed on February 11, 2025
Topics 1 results
More Recent Stories from Quartz
Novo Nordisk, Amgen, CRISPR Therapeutics, and others are set to reveal potentially game-changing trial results this…
Plus, CVS will cut almost 3,000 jobs as it plans AI investments — and considers breaking up
Gene therapy from Orchard Therapeutics promises to treat the underlying causes of a rare genetic disease
U.S. regulators have approved two gene therapies for sickle cell disease
There soon may be a new cure for sickle cell disease that attacks the disorder at its genetic source
ニュースレター「Forecast」では、グローバルビジネスの大きな変化を1つずつ解説しています（これまでに配信してきたニュースレターはこちらからまとめてお読みいただけます）。
Until just decades ago, we had no way to rewrite DNA, the genetic code that programs life. That changed with the…
On the morning of Oct. 7, microbiologist Emmanuelle Charpentier and biochemist Jennifer Doudna received phone calls…
A patent battle that has gone on for years finally came to an end earlier today (Sept. 10).
Not finding what you're looking for? Try searching on all G/O Media sites
CRISPR Therapeutics—a Swiss startup hoping to harness the gene-editing technology it’s named after to develop…
The biotech industry is obsessed with Crispr, the molecular gene-editing technology capable of snipping out…
China is taking the lead in the global race to perfect gene therapies.
Within a few years of the breakthrough discovery that Crispr could be adapted to edit DNA, scientists were already…
For a technology with world-bending potential, most Crispr innovations and businesses can be traced back to…
Gene editing has emerged as another treatment option for genetically inherited human diseases including sickle cell…
Advertisement